Study Finds Serotonin Plays a Role in Development of Mammary Glands
The development of mammary glands is controlled primarily by endocrine hormones. A study led by Nelson Horseman, PhD, professor and interim chair of the Department of Molecular and Cellular Physiology at the
, shows that serotonin (a brain neurotransmitter) also plays a role in mammary gland development. Findings from this study appear in the Feb. 10 issue of
Developmental Cell
in an article titled "Serotonin Regulates Mammary Gland Development via an Autocrine Paracrine Loop."
"It was a complete surprise when we found that serotonin, a chemical best known for its involvement in mood regulation, plays an important role in controlling the secretion of milk in the mammary glands," said Dr. Horseman.
Serotonin, along with other regulatory hormones such as dopamine and adrenaline, is classified as a biogenic monoamine. Until now, this molecule has not been associated with the development of mammary glands. Dr. Horseman's group found that mammary glands stimulated by prolactin express genes necessary for the biosynthesis of serotonin.
Findings from this study may suggest that drugs that alter serotonin synthesis or activity could have effects on milk production, milk quality, or breast cancer.
Co-authors from UC include: Manabu Matsuda, PhD, former postdoctoral fellow; Tatsuhiko Imaoka, PhD, former graduate student; Archie J. Vomachka, PhD, visiting professor from Arcadia University in Pennsylvania; Gary A. Gudelsky, PhD, professor in the UC College of Pharmacy; Zhaoyuan Hou, PhD, former graduate student; Meenakshi Mistry, research associate in the Department of Molecular and Cellular Physiology; Jason P. Bailey, graduate student in the Department of Molecular and Cellular Physiology; and Kathryn M. Nieport, research assistant in the Department of Molecular and Cellular Physiology.
View the entire article online at
Tags
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.
From spilled milk to super-resolution microscopy
April 15, 2026
University of Cincinnati student Eddie Gerstner will graduate this semester and enter medical school later this year. Born with a severe milk allergy, he has overcome numerous life-threatening reactions since.